Canada Life
SNDX icon

Canada Life’s Syndax Pharmaceuticals SNDX Stock Holding History

Canada Life’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Hold
7,182
– – ﹤0.01% 1619
2025
Q4 		$151K Hold
7,182
– – ﹤0.01% 1663
2025
Q3 		$112K Hold
7,182
– – ﹤0.01% 1749
2025
Q2 		$67K Sell
7,182
-13,480
-65% -$148K ﹤0.01% 1811
2025
Q1 		$254K Hold
20,662
– – ﹤0.01% 1704
2024
Q4 		$273K Hold
20,662
– – ﹤0.01% 1721
2024
Q3 		$398K Hold
20,662
– – ﹤0.01% 1719
2024
Q2 		$424K Buy
20,662
+13,480
+188% +$282K ﹤0.01% 1711
2024
Q1 		$171K Buy
7,182
+1,587
+28% +$35.4K ﹤0.01% 1856
2023
Q4 		$120K Hold
5,595
– – ﹤0.01% 1908
2023
Q3 		$81K Buy
5,595
+2,962
+112% +$56K ﹤0.01% 2009
2023
Q2 		$55K Hold
2,633
– – ﹤0.01% 1996
2023
Q1 		$56K Hold
2,633
– – ﹤0.01% 2054
2022
Q4 		$67K Buy
2,633
+813
+45% +$19K ﹤0.01% 2042
2022
Q3 		$44K Hold
1,820
– – ﹤0.01% 2121
2022
Q2 		$35K Hold
1,820
– – ﹤0.01% 2132
2022
Q1 		$34K Hold
1,820
– – ﹤0.01% 2250
2021
Q4 		$40K Hold
1,820
– – ﹤0.01% 2233
2021
Q3 		$35K Hold
1,820
– – ﹤0.01% 2327
2021
Q2 		$31K Hold
1,820
– – ﹤0.01% 2401
2021
Q1 		$40K Hold
1,820
– – ﹤0.01% 2359
2020
Q4 		$40K Buy
+1,820
New +$37.7K ﹤0.01% 2361

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Canada Life's SNDX Position: Q1 2026 in Review

Canada Life held its Syndax Pharmaceuticals (SNDX) position steady in Q1 2026 at 7,182 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Canada Life first reported a position in SNDX in Q4 2020 and has held it in 22 quarters since. The position peaked at $424K in Q2 2024. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Canada Life held 7,182 shares of Syndax Pharmaceuticals worth $169K as of Q1 2026.
  • Canada Life left its Syndax Pharmaceuticals share count unchanged in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1619 holding.
  • Canada Life first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Canada Life's Syndax Pharmaceuticals position peaked at $424K in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.